Member Info for CHELSEA7

optimistical, thank you for your very kind words, as van van said there are some very good posters here, and many more very well researched in Scancell matters. I and others, are still confident here, AIM needs instant news, something which the Biotech industry, with so much clinical work involved and a high failure rate, does not look on kindly.

Might be very good for you, rather than take the p..., is to do the research here, at least when it turns we all have very high holdings, ready for high games. With many patients surviving five, six years from Stage3/4 melanoma I look forward to you showing some courtesy, which Scancell richly deserve. Take care.

Very good posts.

Van Van welcome to the BB.

Delayed sell over on NEX...…………………..

11/10/2018 15:25
75,000
9.77

Pointless post woody, the Pharma will dictate the pricing and it has nothing to do with the cost of manufacture. Pricing is based on R & D costs, marketing and fall in line with other treatments they hold under Patent. Sorry, but yet another example of nonsense and incorrect information.

At he same time the rampers here reckon its worth between 250m and £1b, so it won"t be given away at knockdown prices will it? Try doing some research perhaps.

Buys 90k

Sells 80k

10.11 Paid for 30k just after the two buys sub 10p on NEX. Well done he who got sub 10, …….I think!!!

Good posts Ray, the first one well yes, I think most of us see the potential here still, the frustration is we have to start seeing developments as listed in your second post, which incidently is why I am happy to hold. That's how I see it hopefully turning out. In the meantime we are in the grip of a brutal market. Lets hope the AGM gives good reason to remain positive, the start of deals would be better.

Well I have no desire to speak to you. I have merely said it is plausible. It is so quiet because there is no sentiment!!!

We started the week I believe 4 v 2, and on small volume have slipped to 2 v 5.

Panmure on that bid, as they have when SP is under pressure in recent times.

What news are you expecting TF? Unless it is something new which the BOD wish to expand on at the AGM, I am just happy that we have a date where the scope for progress updates in so many items has never been so great to an audience, whatever the gripes are, are only too happy to hear.

Whatever gripes we all have, I trust will be put aside in the hope the BOD explains the lack of updates, and anything subject to talks of a monetary nature, we will all understand there is very little they can the say. I cannot recall an AGM where the potential for uplifting updates is so great, it is not the lack of communication to assist those trading that bothers me, just many of us are looking forward to how we are progressing since collaborations were RNSed and the Placing and OO executed. If in future the BOD can be more mindful of that, communicate what they can, and at the same time help the SP not reaching the level we see today, I will be happy.

You have gone to great lengths to state you can now understand what many were saying, what is it you hope to be addressed at the AGM,? my own comments and others suggested the BOD could do a lot more in keeping sentiment far better than they have.To me an explanation of the delay in SCIB1 trial is due, a possible update on Grand Challenge and all Moditope platforms, with an outline for what is being planned next.

Unfortunately I do believe the outcome of Grand Challenge will be key to some of that, and IMHO will certainly be key before we hear much more on further funding, which will be needed to trial Moditope, but we still don"t know numbers and sites for the SBIB1 trial which needs addressing. Given the expansive nature of our pipelines, clinical development and progress with our collaborators it should be a good opportunity to gauge where we are, and trust those attending afford the BOD support where appropriate, and all parties leave the AGM happy with the direction we are choosing, and the BOD with a few things to think of in the future too.

It surprises me you could not feel the sentiment from many, slated my opinions, whilst not saying anything to many who shared the same opinion, perhaps playing the ball, not the man, will work better for you.

Buys 1k

Sells 26k

Chester, just seen your earlier post, my thoughts entirely, Rec.

Night Guys

That is the problem, without updates, which I am sure will be put right at the AGM, it leaves many questions. The bigger the pipeline, the more funding will be needed, regardless of our cash position now, which just increases pressure on securing monetary deals.

I wasn't nduly put out when the matter of Kate was debated here, there has been no evidence of Calculas selling, and John Glencross still seems very positive.

We have been here before, but logic dictates a very plausible case that monetary deals may not be so far away. I am happy to hold at this level, not seeking to trade, and not needing to realise cash invested, even going days without checking out the share price. All will be revealed in the next few months, it would be rather illogical to increase renumeration, knowing how much will be needed, allowing the SP to gently slide, without knowing where funding will come from IMHO.

Take Stock, I can"t helping thinking that in Moditope we will see monetary deals first. That is why I feel resources, by that I believe focus and man power is very much on Moditope as a priority. Should be interesting though both SCIB trials are being designed to be short and I would guess qualify for Accelerated Approval when completed. Just my thoughts.

Mind you good for those topping up still, although no evidence anybody is seriously doing so. Seems the target is sub 10.

Good reminder Deadly, some very impressive names there.

Really hoping we do start this trial before end 2018, its funny the lack of news and complete disinterest from the BOD re the SP, does make me feel we have some good news coming soon, more than plausible, and in fairness if there is there is nothing Scancell can say.

Only trouble with lack of updates is it makes shareholders impatient and nervous, maybe that with the SP at 10/10.50 the BOD might consider at the AGM for the future.

""""So C7 you seem to have also assumed that the trial dates will not start on time as set out in the end of year forward statements ?

or are you just agreeing with everybody as a sign of solidarity ..""

What a silly post. I would remind you I was the first to express those feelings three months ago, funny enough you were the only one, along with TF insulted me then too.

Not really bothered, forgetting even impact on the SP there are many of us just wanting to see us back in trials, extending human life, it would not be normal not to wonder why it hasn"t started yet, and I have never thought it was an Ichor issue.

Night.

Can"t see any reason to disagree with what you first posted. For many of us an explanation would probably suffice, especially considering funds have been raised with the purpose of funding the SCIB 1 trial.

Trouble is without that explanation it begs to look for reasons, which will often cause fear, and often way off the mark. The delay now runs into years, not months, and I have wondered whether the BOD have prioritised other components of our pipeline, with clearly better chances of seeking commercialabity than the Immunobody platform.?? Yes, IMHO we are actually entitled to an explanation, and I hope is that forthcoming at the AGM, and does not eclipse the potential positivity that might exist elsewhere.

"""Anyway read the RNS’s as its not my job to spoon feed you"""- Priceless!!!

How about reassuring investors who are becoming very angry with the empty promises from you, and your refusal to back up any of your posts.

Truth is you can"t back up what you post, ever. Will leave you to others Uncanny, it don"t work anymore, you have been spotted.

As ever you cannot back up your posts with fact.

Gilders, can you tell me what is remarkable.

Not one trial patient is alive!!!